MALATHION Drug Patent Profile
✉ Email this page to a colleague
When do Malathion patents expire, and what generic alternatives are available?
Malathion is a drug marketed by Norvium Bioscience and Suven Pharms and is included in two NDAs.
The generic ingredient in MALATHION is malathion. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the malathion profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Malathion
A generic version of MALATHION was approved as malathion by SUVEN PHARMS on May 23rd, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MALATHION?
- What are the global sales for MALATHION?
- What is Average Wholesale Price for MALATHION?
Summary for MALATHION
Recent Clinical Trials for MALATHION
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| London School of Hygiene and Tropical Medicine | Phase 3 |
| Taro Pharmaceuticals USA | Phase 1 |
| Taro Pharmaceuticals USA | Phase 2/Phase 3 |
Pharmacology for MALATHION
| Drug Class | Cholinesterase Inhibitor |
| Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for MALATHION
Anatomical Therapeutic Chemical (ATC) Classes for MALATHION
US Patents and Regulatory Information for MALATHION
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norvium Bioscience | MALATHION | malathion | LOTION;TOPICAL | 078743-001 | Mar 6, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Suven Pharms | MALATHION | malathion | LOTION;TOPICAL | 091559-001 | May 23, 2012 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
